행사/교육
World Stem Cells & Regenerative Medicine Congress
- 등록일2013-02-25
- 조회수4136
- 구분 국외
- 행사교육분류 행사
-
주관기관
Terrapinn Pte Ltd
-
행사장소
Resorts World Sentosa - Singapore
-
행사기간
2013-03-18 ~ 2013-03-21
- 원문링크
- 첨부파일
brochure.pdf 1.pdf
World Stem Cells & Regenerative Medicine Congress
conference programme
Conference Day One, 19 March 2013, Tuesday
conference
08.00 Registration and refreshments
08.40 Organiser's welcome remarks: Terrapinn Asia
BIOPHARMA LEADERSHIP FORUM: ASIAN & GLOBAL LEADERSHIP PANEL
09.00 Keynote Plenary Session: Rebuilding the pharma business model to achieve sustainability and greater R&D efficiency
10.20 Morning refreshments, exhibition visit and academic poster showcase
MARKET OPPORTUNITIES IN ASIA
11.15 Chairman's opening remarks
11.25 Keynote Panel: Assessing commercial opportunities and challenges for stem cell applications in Asia
› Mr Chrisitian H.Leist, Leading Scientist, Head Cell & Gene Therapy, Switzerland› Zhong Zhong, Senior Director, GlaxoSmithKline, China Keynote Panel: Assessing commercial opportunities and challenges for stem cell applications in Asia
11.55 The pros and cons of setting up large scale manufacturing and the growing need for collaboration among stem cell manufacturers in the global market for "High" potency stem cells in clinical medicine
› Mr Nikolai Tankovich, CEO, Stemedica, United States
The pros and cons of setting up large scale manufacturing and the growing need for collaboration among stem cell manufacturers in the global market for "High" potency stem cells in clinical medicine
12.25 Networking luncheon, exhibition visit and academic poster showcase
STEM CELL APPLICATION IN DIFFERENT THERAPEUTIC AREAS
14.00 Stem cell therapy for strokes: Lost in translation
› Mr Cesar V Borlongan, Professor and Vice Chairman for Research,Department of Neurosurgery and Brain Repair Director, Center of Excellence for Aging and Brain Repair,University of South Florida College of Medicine, United States
Stem cell therapy for strokes: Lost in translation
14.20 Modeling human diseases with hES and iPS derived neurons
14.40 Regulation of the Wnt signaling pathway as a therapeutic approach in cancer and stem cell biology
› Dr David M Virshup, Professor ( Cancer & Stem Cell Biology Program), Duke Nus, Singapore
Regulation of the Wnt signaling pathway as a therapeutic approach in cancer and stem cell biology
15.00 Evaluating the efficacy and safety of adipose mesenchymal stem cells against osteoarthritis and clinical limb ischemia
› Dr N.K Venkataramana, Neurosurgeon,Director advanced Neuro Science Institute, BGS Global Hospital, India Evaluating the efficacy and safety of adipose mesenchymal stem cells against osteoarthritis and clinical limb ischemia
15.20 Afternoon refreshments, exhibition visit and academic poster showcase
TRANSLATIONAL REGENERATIVE MEDICINE
16.00 Adult adherent stem cells for treatment of CNS injury and disease
› Robert Deans, EVP, Regenerative Medicine, Athersys, United States Adult adherent stem cells for treatment of CNS injury and disease
16.20 Applications of artificial bone marrow microenvironments (ABME) in regenerative medicine
› Dr Vaijayanti Kale, Scientist, National Centre for Cell Science, India Applications of artificial bone marrow microenvironments (ABME) in regenerative medicine
16.40 The challenges in bringing stem cell based research to the bed side in the Indian context
› Ms Chandra Viswanathan, SVP Regenerative Medicine, Reliance Life Sciences, India
The challenges in bringing stem cell based research to the bed side in the Indian context
17.00 Applications of iPSC platform for diagnosis and treatment of cardiovascular diseases
› Mr Hung-Fat Tse, Professor,Cardiology Division, Department of Medicine, The University of Hong Kong, Hong Kong Applications of iPSC platform for diagnosis and treatment of cardiovascular diseases
17.20 Chairman's closing remarks
17.30 End of conference day one
Conference Day Two, 20 March 2013, Wednesday
conference
08.00 Registration and refreshments
08.50 Chairman's opening remarks
PARTNERSHIPS & INVESTMENT IN STEM CELL INNOVATIONS IN ASIA
09.00 Partnership Panel: Strategic collaboration of pharmas, biotechs and research institutes in driving stem cell research and application in Asia
› Dr Gilson Khang, Department Head,Director Biomaterials & Tissue Eng'g Lab,, Department of PolymerNano Science & Technology,Chonbuk National University, Republic Of Korea› Robert Deans, EVP, Regenerative Medicine, Athersys, United States Partnership Panel: Strategic collaboration of pharmas, biotechs and research institutes in driving stem cell research and application in Asia
09.20 Analysing the world's first off the shelf allogenic cord-blood stem cell drug CARTISEM - Journey to the market from scratch
› Mr Jay Lee, Senior Director in Business Development, MEDIPOST Co Ltd, Republic Of Korea
Analysing the world's first off the shelf allogenic cord-blood stem cell drug CARTISEM - Journey to the market from scratch
09.40 Investor Panel: Evaluating potential investment opportunities in specific stem cell research and their appliciation in Asia
› Ms Hui Hsing Ma, Venture Partner for Life Science, TVM Capital, Germany› Mr Michael Keyoung, Managing Director, Pan Asia, United States
Investor Panel: Evaluating potential investment opportunities in specific stem cell research and their appliciation in Asia
10.20 Morning refreshments, exhibition visit and academic poster showcase
COMMERCIALISATION & BUSINESS MODELS
11.15 Recent advances in commercialisation of regenerative medicinal products in Korea
› Dr Gilson Khang, Department Head,Director Biomaterials & Tissue Eng'g Lab,, Department of PolymerNano Science & Technology,Chonbuk National University, Republic Of Korea
Recent advances in commercialisation of regenerative medicinal products in Korea
11.35 Unravelling new business models and commercialisation of autologous/ allogenic stem cell therapy and regenerative products
› Mr Mohamed Gaballa, Director,Center for Cardiovascular research, Banner SunHealth Research Institute, United States Unravelling new business models and commercialisation of autologous/ allogenic stem cell therapy and regenerative products
11.55 Stem cells research in Israel and Hebrew University- A true success story
12.15 The UK cell therapy catapult- A new initiative to bridge the translation gap for cell therapies
› Dr Natalie Mount, Chief Clinical Officer, Cell Therapy Catapult Limited, United Kingdom
The UK cell therapy catapult- A new initiative to bridge the translation gap for cell therapies
12.35 Networking luncheon, exhibition visit and academic poster showcase
INNOVATIONS IN STEM CELLS & REGENERATIVE MEDICINE
14.00 Redesigning biological scaffold to make "tailor made" organs using stem cells
› Ms Suchitra Holgersson, Professor, Goteborf University, Sweden
Redesigning biological scaffold to make "tailor made" organs using stem cells
14.30 Development of autologous cell therapy products with GMP compliant manufacturing- RMS Regrow approach
15.00 Introducing non-invasive imaging of stem cells
› Mr Chrisitian H.Leist, Leading Scientist, Head Cell & Gene Therapy, Switzerland
Introducing non-invasive imaging of stem cells
RAPID FIRE R&D SHOWCASE
16.00 Understanding post transcriptional controls of ES cell self-renewal and differentiation
› Dr Leah Vardy, Principal Investigator, A*STAR, Singapore Understanding post transcriptional controls of ES cell self-renewal and differentiation
16.50 Chairman's closing remarks
17.00 End of conference day two
........(계속)
☞ 자세한 내용은 내용바로가기를 이용하시기 바랍니다.